Michele Magremanne - Publications

Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: April 12, 2025

Osteonecrosis of the jaw associated with ustekinumab in the treatment of Crohn's.

Journal: Heliyon

Published: July 26, 2024

Study of the PD-L1 expression, T-cells density and immunoscore in paired baseline tumor biopsies and surgical specimens in squamous cell carcinoma of the oral cavity.

Journal: Oral oncology

Published: March 21, 2024

Comparable Accuracy of Quantitative and Visual Analyses of [18F]FDG PET/CT for the Detection of Lymph Node Metastases from Head and Neck Squamous Cell Carcinoma.

Journal: Diagnostics (Basel, Switzerland)

Published: July 10, 2023

Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 15, 2023